|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
FY2020
12 months to Sep 30, 2020
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for loan losses | |||||
| (Release of) provision for credit losses | |||||
| Provision for depreciation and amortization | |||||
| Amortization and accretion of discounts and premiums, net | |||||
| Net loss on sale of investment securities | |||||
| Compensation expense on ESOP | |||||
| Stock-based compensation | |||||
| Amortization of right-of-use-asset | |||||
| Unrealized loss on equity securities | |||||
| Gain on sale of loans, net | |||||
| Origination of mortgage loans sold | |||||
| Proceeds from sale of mortgage loans originated for sale | |||||
| Origination of residential real estate loans for sale | |||||
| Proceeds from sale of residential real estate loans | |||||
| Increase in accrued interest receivable | |||||
| (Decrease) increase in accrued interest payable | |||||
| Earnings on bank-owned life insurance | |||||
| Deferred federal income taxes | |||||
| Decrease in accrued pension liability | |||||
| Loss on foreclosed real estate | |||||
| Amortization of intangible assets | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Investment securities available for sale: | |||||
| Proceeds from sale of investment securities | |||||
| Proceeds from principal repayments and maturities | |||||
| Purchases | |||||
| Investment securities held to maturity: | |||||
| Proceeds from principal repayments and maturities | |||||
| Purchases | |||||
| (Increase) decrease in loans receivable, net | |||||
| Increase in loans receivable, net | |||||
| Redemption of regulatory stock | |||||
| Purchase of regulatory stock | |||||
| Proceeds from sale of foreclosed real estate | |||||
| Purchase of premises, equipment, and software | |||||
| Net cash provided by (used for) investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Decrease (increase) in deposits, net | |||||
| Net (decrease) increase in short-term borrowings | |||||
| Proceeds from other borrowings | |||||
| Increase (decrease) in advances by borrowers for taxes and insurance | |||||
| Purchase of common stock | |||||
| Dividends on common stock | |||||
| Net cash (used for) provided by financing activities | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS AT END OF YEAR | |||||
| Cash paid: | |||||
| Interest | |||||
| Income taxes | |||||
| Noncash items: | |||||
| Transfers from loans to foreclosed real estate | |||||
| Initial recognition of operating right-of-use asset | |||||
| Initial recognition of operating lease liability | |||||
| Unrealized holding gain (loss) on investment securities available for sale | |||||
Loading...